Comments
LifeCell, a stem cell bank, will set up a facility in Jhajjar, Haryana at an investment of ₹25 crore to produce Mesenchymal Stem Cells.
Mesenchymal Stem Cells are a type of master stem cells that have the potential to form bone, cartilage, muscle and adipose tissues, thereby making them capable of being used in several therapeutic areas. The MSC can be made available off-the-shelf for immediate treatment as they don’t need donor-recipient matching.
The facility, which will also run clinical trials, will be operational in three years.
Mayur Abhaya, Managing Director and Chief Executive Officer, LifeCell, said in a press release: “This initiative would allow people to have access to high quality MSC and we are very happy to make the first move in the industry by making it affordable by providing high quality of stem cells for treatment... We are certain we would be able to make this product available in the country in the coming years.”
For stem cell banking clients, it would offer many advantages as families can now get immediate, off-the-shelf access to these stem cells instead of having to wait up to 12 weeks for clinical expansion of their own baby’s stem cells.
In the light of this development, LifeCell will also make changes to its stem cell banking programme, whereby instead of private banking of umbilical cord tissue, it would alternatively offer donor-derived umbilical cord tissue MSC.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.